Tag Archives: EliA
Thermo Fisher to offer senior notes to raise funds for Phadia acquisition
In an attempt to fund its acquisition to buy privately held Swedish firm Phadia for $3.5 billion, Thermo Fisher Scientific (NYSE:TMO) says it will offer senior notes to raise the capital required.
The scientific instrument maker first made it known …
Posted in Healthcare, Latest Headlines
|
Tagged acquisition, allergy, auction, Barclays Capital, BCS, brokers, capital, deal, EliA, immune dieseases, ImmunoCap, JP Morgan, JPM, NYSE, NYSE:BCS, NYSE:JPM, NYSE:TMO, phadia, privately held, senior notes, Thermo Fisher, TMO
|
Comments Off















